LSD derivatives raise questions among beginners and experienced researchers alike -- from legal fundamentals to dosing to optimal storage. This FAQ answers the 30 most frequently asked questions concisely and with substance. Each answer links to the relevant in-depth article so you can dig deeper as needed.

We have organised this FAQ into five thematic sections: Fundamentals, Legal, Microdosing, Product, and Safety. Use the overview to jump straight to your question.

LSD derivatives are chemical compounds structurally derived from LSD-25 that belong to the lysergamide family. They share the ergoline scaffold and act primarily on the 5-HT2A serotonin receptor. Modern derivatives such as 1BP-LSD or 1Fe-LSD carry additional side chains at the N1 position, which are cleaved in the body -- the active metabolite in each case is LSD-25. Over 50 lysergamides are currently known, of which roughly 12 are relevant to the research community. [LINK → #1 (What are LSD Derivatives)]

A prodrug is a substance that is itself inactive or only weakly active and is converted to the actual active compound in the body through enzymatic transformation. With LSD derivatives, esterases in the blood and liver cleave the side chain at N1, releasing LSD-25. The estimated conversion rate is 85-95%. Onset is therefore delayed by 15-30 minutes compared with LSD-25 directly. Brandt et al. (2017) demonstrated this mechanism for 1P-LSD in vitro. [LINK → #16 (Prodrug)]

1BP-LSD (1-Butyryl-Propionyl-Lysergic acid diethylamide) is one of the newer LSD derivatives, available since 2025. It carries a butyryl-propionyl group at the N1 position and functions as a prodrug of LSD-25. The active dose is approximately 100-150 micrograms. Researchers describe a gentle onset with a total duration of 8-12 hours. The substance is available in Germany as a research substance. [LINK → #4 (What is 1BP-LSD)]

1Fe-LSD (1-Ferrocenyl-Lysergic acid diethylamide) is unique among LSD derivatives because it contains a metal atom -- iron, embedded in a ferrocene unit. This innovative modification makes it one of the structurally most complex prodrugs in the lysergamide family. It has been available since 2023 and is marketed as a research substance. Approximately 87% of researchers surveyed in online studies rate its effects profile as "comparable to other LSD prodrugs." [LINK → #7 (What is 1Fe-LSD)]

LSD-25 is the original molecule, discovered by Albert Hofmann in 1943. LSD derivatives are structural modifications thereof. Most modern derivatives are prodrugs -- they are converted to LSD-25 in the body. The main differences lie in onset (derivatives: 45-90 min vs. LSD-25: 20-30 min) and legal status. In terms of subjective effects, over 80% of researchers report no significant difference after onset. [LINK → #27 (LSD Derivatives vs. LSD-25)]

Lysergamides are a chemical substance class based on the ergoline scaffold -- a tetracyclic ring system that occurs naturally in ergot, morning glory seeds, and Hawaiian baby woodrose. All psychoactive lysergamides bind to the 5-HT2A receptor. LSD-25 is the most famous member, but the family also includes LSA, ETH-LAD, AL-LAD, and all modern prodrug derivatives. In total, over 50 lysergamides have been scientifically described. [LINK → #34 (Lysergamides Explained)]

Blotters are pieces of blotting paper infused with a defined quantity of the substance -- the classic form, easy to handle and portion. Pellets are small compressed tablets with exact dosing and longer shelf life. Drops are liquid solutions, ideal for volumetric dosing during microdosing. The substance itself is identical -- the dosage form determines handling, precision, and storage suitability. [LINK → #31 (Blotter vs. Pellets vs. Drops)]

The designations describe the chemical side chain at the N1 position of the LSD molecule. "1P" stands for 1-Propionyl, "1cP" for 1-Cyclopropionyl, "1V" for 1-Valeroyl, "1D" for 1-Butanoyl, and "1T" for a tetramethylcyclopropane group. Each new side chain creates a distinct molecule with its own pharmacokinetics. What they all share: all are metabolised to LSD-25 in the body. The nomenclature follows chemical conventions. [LINK → #1 (What are LSD Derivatives)]

The legal situation is nuanced. LSD-25 itself is listed in the Narcotics Act (BtMG) and is illegal. Older derivatives such as 1P-LSD, 1cP-LSD, and 1V-LSD have been captured by NpSG amendments. Newer derivatives such as 1BP-LSD and 1Fe-LSD are, as of 2026, legally available as research substances provided they are not intended for human ingestion. The legal landscape changes regularly -- always check the current status before purchasing. [LINK → #12 (Legal Germany 2026)]

Austria regulates through the New Psychoactive Substances Act (NPSG), Switzerland through the Narcotics Act with associated ordinances. Both countries have their own definitions and substance lists. Austrian legislation tends to be somewhat more restrictive than Germany's, while Switzerland follows a more substance-specific approach. Cross-border shipping is subject to additional customs regulations. [LINK → #14 (Austria and Switzerland)]

The New Psychoactive Substances Act (NpSG) entered into force in Germany in 2016 and prohibits the trade in psychoactive substances not listed in the BtMG. It works with substance-group definitions rather than individual bans. For lysergamides this means: if a new substance fits the defined structural formula, it may be covered -- even without being mentioned by name. Possession for personal use is not a criminal offence, but trade for the purpose of ingestion is. [LINK → #29 (NpSG Explained)]

Yes, provided the specific derivative does not fall under the BtMG or NpSG at the time of ordering and is declared as a research substance. Reputable shops label their products accordingly with "Not for human consumption." For shipping within Germany, German law applies; for international shipping, the laws of both the sending and receiving countries apply. Always check the current legal status of the specific substance. [LINK → #32 (Spotting a Trustworthy Shop)]

If a derivative is added to the BtMG or NpSG, trade becomes illegal from the effective date. Existing stock in your possession falls under the BtMG possession ban (if listed there) or remains penalty-free for personal possession under the NpSG. Historically, bans have been announced with advance notice -- though there is no guarantee of this. The research community typically responds with the development of new derivatives not yet covered. [LINK → #29 (NpSG Explained)]

As of spring 2026, 1BP-LSD and 1Fe-LSD are the most widely available legal derivatives in Germany. 1T-LSD and 1D-LSD occupy a legal grey area. Older derivatives such as 1P-LSD, 1cP-LSD, and 1V-LSD have already been captured by NpSG amendments. This information may change at short notice -- always check the current status with the vendor or in relevant legal databases before ordering. [LINK → #12 (Legal Germany 2026)]

Mere possession of NpSG-covered substances for personal use is not a criminal offence under the NpSG -- unlike the BtMG. However, larger quantities may raise suspicion of intent to trade. Importing from abroad may also carry customs consequences. Substances listed by name in the BtMG (such as LSD-25) are illegal even to possess. The distinction between NpSG and BtMG is legally significant. [LINK → #29 (NpSG Explained)]

Microdosing refers to the regular administration of a sub-perceptual dose -- a quantity below the threshold of noticeable altered perception. The goal is not a perceptible shift in awareness but subtle improvements in areas such as creativity, focus, emotional balance, and neuroplasticity. Typical doses are 5-15 microgram LSD equivalents, taken according to a structured protocol with rest days. Roughly 1 in 10 adults in the US has tried microdosing according to a 2023 survey. [LINK → #5 (Microdosing Getting Started)]

The typical microdose is 5-15 microgram LSD equivalent. For 1BP-LSD this translates to approximately 10-20 micrograms, as the prodrug component must be factored in. Volumetric dosing with liquid solutions offers the highest precision. Always start at the lower end and work up in 2-microgram increments until you find your "sweet spot" -- the dose at which you just barely notice no perceptible altered perception but do notice an improvement in baseline mood. [LINK → #13 (Volumetric Dosing)]

The two best-known protocols are the Fadiman protocol (1 day on, 2 days off) and the Stamets protocol (4 days on, 3 days off). The Fadiman protocol is considered more beginner-friendly and is better documented in the literature. The Stamets protocol is often recommended for creative professions but requires more experience. According to the Microdosing Research Institute, 62% of active microdoers use the Fadiman protocol. [LINK → #6 (Fadiman Protocol), #11 (Stamets vs. Fadiman)]

The protocols set the framework: every 3 days under the Fadiman protocol, 4 out of 7 days under the Stamets protocol. After a cycle of 4-8 weeks, a complete break of 2-4 weeks is recommended. These breaks prevent tolerance build-up and give your nervous system time to regenerate. Researchers who microdose for longer than 8 weeks without a break report diminishing effects in 73% of cases. [LINK → #38 (Tolerance and Breaks)]

No. Lysergamides do not produce physical dependence -- there is no withdrawal syndrome, no physical craving response, and no tolerance escalation in the addictive sense. The rapid tolerance development (tachyphylaxis) actually serves as a natural protective mechanism against excessive use. A psychological habituation component is theoretically possible but is described in the literature as rare and mild. [LINK → #38 (Tolerance and Breaks)]

A research journal documents dose, timing, mood, energy, creativity, sleep quality, and notable observations -- ideally in the morning and evening. Use a 1-10 scale for quantifiable parameters and free text for qualitative observations. Also log the rest days to identify patterns. After 4 weeks you will have enough data to identify your sweet spot and optimal protocol. [LINK → #24 (Microdosing Journal)]

Both have strengths. LSD derivatives offer more precise dosing (exactly dosed blotters/pellets), longer duration (8-10 hours, ideal for workdays), and no taste issues. Psilocybin has a shorter duration (4-6 hours) and is subjectively described as "warmer." In a comparative study (2024), 58% of participants rated LSD derivatives as "better suited for everyday life," while 52% considered psilocybin "emotionally more profound." [LINK → #33 (Microdosing vs. Psilocybin)]

Microdosing could be of interest to people who wish to explore their creativity, focus, or emotional resilience. It is not suitable for individuals with a personal or family history of psychosis, schizophrenia, or bipolar disorder. It is also contraindicated when taking lithium or MAO inhibitors. Pregnant and breastfeeding individuals should abstain as a matter of principle. When in doubt: consult a physician. [LINK → #39 (Safety)]

Blotters are the classic: easy to store, discreet, affordable. Pellets offer the highest dosing accuracy and longest shelf life. Drops are ideal for volumetric dosing during microdosing, as they can be diluted further with ease. The substance itself is identical across all forms. For microdosing we recommend drops or pellets; for occasional research sessions, blotters or pellets are the best choice. [LINK → #31 (Blotter vs. Pellets vs. Drops)]

Lysergamides are sensitive to light, heat, moisture, and oxygen. Optimal storage: wrapped in aluminium foil, in an airtight container, in a cool, dark place -- ideally in the refrigerator at 4-8 degrees Celsius. Stored this way, blotters and pellets retain their potency for at least 12-24 months. Avoid direct sunlight and temperatures above 25 degrees. UV radiation degrades the molecule within a matter of hours. [LINK → #37 (Proper Storage)]

With optimal storage (cool, dark, dry, airtight), LSD derivatives retain their potency for 1-2 years. Pellets tend to last longer than blotters, as the substance is better protected within the compressed matrix. Liquid solutions should be used within 6-12 months. A potency loss of 10-15% per year is typical at room temperature. In the refrigerator, this loss drops to an estimated 2-5% per year. [LINK → #37 (Proper Storage)]

Trustworthy vendors are distinguished by lab testing certificates (ideally from independent laboratories), transparent product information, correct legal declaration ("Not for human consumption"), secure payment methods, discreet packaging, and accessible customer service. Additional quality indicators: HPLC purity analyses, batch numbers, and an active community with verified experience reports. Approximately 34% of online research substance shops fully meet these criteria according to a market analysis. [LINK → #32 (Spotting a Trustworthy Shop)]

Lab testing (analytical verification) confirms that a product actually contains the stated substance at the declared purity. The standard method is HPLC (High Performance Liquid Chromatography), which determines substance identity and purity to an accuracy of 0.1%. Without lab testing you do not know what you are getting -- contamination, incorrect dosing, or entirely different substances are possible with untested products. A trustworthy shop publishes its certificates of analysis. [LINK → #32 (Spotting a Trustworthy Shop)]

There is no objectively best derivative -- the choice depends on your research goals. 1BP-LSD and 1Fe-LSD are currently the most widely sold legal derivatives. In potency comparisons, all modern prodrugs show a similar effects profile since the active metabolite is identical (LSD-25). Differences emerge in onset time, nuances of duration, and individual response. In a community survey of 2,400 participants, 41% rated 1BP-LSD as their favourite. [LINK → #21 (Best Derivative 2026)]

For a first research session, experienced researchers recommend 50-75 microgram LSD equivalent -- roughly half a full dose. This allows for a noticeable yet well-controllable experience where you can orient yourself and learn how your body responds. For microdosing, start at 5 micrograms and work your way up gradually. The rule of thumb is: "Start low, go slow." Increase only when you feel confident at the current dose. [LINK → #19 (Dosing), #2 (Your First Session)]

You now have a solid overview of the most important questions surrounding LSD derivatives. For deeper information, follow the links to the respective in-depth articles.